Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor

The lack of model systems has limited the preclinical discovery and testing of therapies for Wilms tumor (WT) patients who have poor outcomes. Herein, we establish 45 heterotopic WT patient-derived xenografts (WTPDX) in CB17 scid(-/-) mice that capture the biological heterogeneity of Wilms tumor (WT...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Andrew J., Chen, Xiang, Pinto, Emilia M., Williams, Justin S., Clay, Michael R., Pounds, Stanley B., Cao, Xueyuan, Shi, Lei, Lin, Tong, Neale, Geoffrey, Morton, Christopher L., Woolard, Mary A., Mulder, Heather L., Gil, Hyea Jin, Rehg, Jerold E., Billups, Catherine A., Harlow, Matthew L., Dome, Jeffrey S., Houghton, Peter J., Easton, John, Zhang, Jinghui, George, Rani E., Zambetti, Gerard P., Davidoff, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925259/
https://www.ncbi.nlm.nih.gov/pubmed/31862972
http://dx.doi.org/10.1038/s41467-019-13646-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925259/
https://www.ncbi.nlm.nih.gov/pubmed/31862972
http://dx.doi.org/10.1038/s41467-019-13646-9

Ejemplares similares